Literature DB >> 33668117

Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.

Ko-Jen Li1, Cheng-Han Wu1,2, Cheng-Hsun Lu1,2, Chieh-Yu Shen1,2, Yu-Min Kuo1, Chang-Youh Tsai3, Song-Chou Hsieh1, Chia-Li Yu1.   

Abstract

The term trogocytosis refers to a rapid bidirectional and active transfer of surface membrane fragment and associated proteins between cells. The trogocytosis requires cell-cell contact, and exhibits fast kinetics and the limited lifetime of the transferred molecules on the surface of the acceptor cells. The biological actions of trogocytosis include information exchange, cell clearance of unwanted tissues in embryonic development, immunoregulation, cancer surveillance/evasion, allogeneic cell survival and infectious pathogen killing or intercellular transmission. In the present review, we will extensively review all these aspects. In addition to its biological significance, aberrant trogocytosis in the immune system leading to autoimmunity and immune-mediated inflammatory diseases will also be discussed. Finally, the prospective investigations for further understanding the molecular basis of trogocytosis and its clinical applications will also be proposed.

Entities:  

Keywords:  amoebic trogocytosis, cell clearance; antibody-dependent cell-mediated cytotoxicity; antigen modification; chimeric antigen receptor T lymphocyte; immune plasticity; oncologic trogocytosis; trogocytosis; tumor evasion; tumor surveillance

Mesh:

Year:  2021        PMID: 33668117      PMCID: PMC7956485          DOI: 10.3390/ijms22052236

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  165 in total

Review 1.  HLA-G: from biology to clinical benefits.

Authors:  Edgardo D Carosella; Philippe Moreau; Joël Lemaoult; Nathalie Rouas-Freiss
Journal:  Trends Immunol       Date:  2008-02-04       Impact factor: 16.687

2.  Trogocytosis in allogeneic transplants: donor cells take on the recipients identity.

Authors:  Ian M Rogers
Journal:  Chimerism       Date:  2013-10-11

3.  Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells.

Authors:  Masafumi Nakayama; Kazuyoshi Takeda; Mitsuko Kawano; Toshiyuki Takai; Naoto Ishii; Kouetsu Ogasawara
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

Review 4.  The Dynamics of Apoptotic Cell Clearance.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  Dev Cell       Date:  2016-07-25       Impact factor: 12.270

5.  Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Authors:  Céline Monnet; Sylvie Jorieux; Nathalie Souyris; Ouafa Zaki; Alexandra Jacquet; Nathalie Fournier; Fabien Crozet; Christophe de Romeuf; Khalil Bouayadi; Rémi Urbain; Christian K Behrens; Philippe Mondon; Alexandre Fontayne
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

6.  Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.

Authors:  Ramraj Velmurugan; Dilip K Challa; Sripad Ram; Raimund J Ober; E Sally Ward
Journal:  Mol Cancer Ther       Date:  2016-05-25       Impact factor: 6.261

7.  Human neutrophil-mediated cytotoxicity to tumor cells.

Authors:  T L Gerrard; D J Cohen; A M Kaplan
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

8.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov; Pratik S Bhojnagarwala; Jon G Quatromoni; Tom Li Stephen; Anjana Ranganathan; Charuhas Deshpande; Tatiana Akimova; Anil Vachani; Leslie Litzky; Wayne W Hancock; José R Conejo-Garcia; Michael Feldman; Steven M Albelda; Sunil Singhal
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

9.  CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells.

Authors:  B R Blazar; F P Lindberg; E Ingulli; A Panoskaltsis-Mortari; P A Oldenborg; K Iizuka; W M Yokoyama; P A Taylor
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

Review 10.  The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.

Authors:  Natasha Ustyanovska Avtenyuk; Nienke Visser; Edwin Bremer; Valerie R Wiersma
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

View more
  5 in total

Review 1.  Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation.

Authors:  Tsai-Hung Wu; Song-Chou Hsieh; Tsu-Hao Li; Cheng-Hsun Lu; Hsien-Tzung Liao; Chieh-Yu Shen; Ko-Jen Li; Cheng-Han Wu; Yu-Min Kuo; Chang-Youh Tsai; Chia-Li Yu
Journal:  Biomedicines       Date:  2022-03-25

2.  Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis.

Authors:  Jae Hun Shin; Jaekwang Jeong; Stephen E Maher; Heon-Woo Lee; Jaechul Lim; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 12.779

3.  Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes.

Authors:  Fabrizio Mattei; Sara Andreone; Francesca Spadaro; Francesco Noto; Antonella Tinari; Mario Falchi; Silvia Piconese; Claudia Afferni; Giovanna Schiavoni
Journal:  iScience       Date:  2022-09-12

Review 4.  The Role of Trogocytosis in the Modulation of Immune Cell Functions.

Authors:  Kensuke Miyake; Hajime Karasuyama
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

Review 5.  Shaping of T Cell Functions by Trogocytosis.

Authors:  Masafumi Nakayama; Arisa Hori; Saori Toyoura; Shin-Ichiro Yamaguchi
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.